Rnc Capital Management LLC Novartis Ag Transaction History

Rnc Capital Management LLC

$1.84 Billion
Q3 2024

A detailed history of Rnc Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Rnc Capital Management LLC holds 3,682 shares of NVS stock, worth $362,124. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,682

Previous 3,682 -0.0%

Holding current value

$362,124

Previous $391,000 8.18%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $1,481 - $1,717	16 Added 0.44%	3,682 $391,000
Q1 2024 Aug 07, 2024	SELL	$95.27 - $108.47 $13,433 - $15,294	-141 Reduced 3.7%	3,666 $354,000
Q4 2023 Jan 17, 2024	BUY	$92.27 - $101.54 $51,671 - $56,862	560 Added 17.25%	3,807 $384,000
Q3 2023 Dec 27, 2023	SELL	$94.73 - $105.13 $26,429 - $29,331	-279 Reduced 7.91%	3,247 $330,000
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $16,746 - $18,988	-181 Reduced 4.88%	3,526 $356,000
Q1 2023 Apr 21, 2023	BUY	$80.03 - $92.81 $10,243 - $11,879	128 Added 3.58%	3,707 $341,000
Q4 2022 Jan 10, 2023	SELL	$75.55 - $92.52 $37,397 - $45,797	-495 Reduced 12.15%	3,579 $325,000
Q3 2022 Oct 18, 2022	SELL	$74.61 - $87.26 $6,043 - $7,068	-81 Reduced 1.95%	4,074 $310,000
Q2 2022 Jul 22, 2022	BUY	$80.52 - $93.75 $7,166 - $8,343	89 Added 2.19%	4,155 $351,000
Q1 2022 Jul 22, 2022	BUY	$80.11 - $90.62 $11,215 - $12,686	140 Added 3.57%	4,066 $357,000
Q4 2021 Feb 04, 2022	BUY	$79.7 - $88.13 $98,429 - $108,840	1,235 Added 45.89%	3,926 $343,000
Q3 2021 Nov 02, 2021	BUY	$81.78 - $95.14 $30,667 - $35,677	375 Added 16.19%	2,691 $220,000
Q2 2021 Jul 20, 2021	BUY	$85.24 - $94.15 $197,415 - $218,051	2,316 New	2,316 $211,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rnc Capital Management LLC with notifications on news.

Account

Rnc Capital Management LLC Novartis Ag Transaction History